Devatis AG

Devatis AG is a Generics company based in Cham (Zug) recorded by Swissmedic as the authorisation holder for 34 human medicines. That places it 47 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.

Key facts

Sector	Generics
City	Cham
Canton	Zug
Authorisation holder	Yes
Medicines	34
Founded	2018
Employees	1-10
Parent group	Not available
Activity	Not available
Website	devatis.ch

Medicines authorised in Switzerland

Devatis AG is recorded by Swissmedic as the authorisation holder for 34 human medicines. The table shows 34 of them with product code and dispensing category.

Portfolio by product code

Synthetika34

Portfolio by dispensing category

34 of 34 authorisations

Name	Authorisation number	Dispensing category	ATC	First authorised
Abirateron Devatis 500 mg	68981	B	L02BX03	2023-10-04
Ambrisentan Devatis 5 mg	67799	B	C02KX02	2020-10-29
Anastrozol Devatis 1 mg	65922	B	L02BG03	2016-07-25
Apixaban Devatis 2.5 mg	70399	B	B01AF02	2026-04-15
Apremilast Devatis 10 mg	70016	B	L04AA32	2025-07-22
Calcitriol Devatis 0	69164	B	A11CC04	2024-03-21
Cefuroxim Devatis i.v. 250 mg	63086	A	-	2014-12-18
Cinacalcet Devatis 30 mg	65919	B	H05BX01	2016-09-30
Co-Amoxicillin Devatis 1 g	67329	A	J01CR02	2019-07-24
Co-Amoxicillin Devatis 312	67384	A	J01CR02	2020-05-07
Co-Amoxicillin Devatis 457 (400 mg / 57 mg)	67383	A	J01CR02	2020-05-07
Co-Amoxicillin Devatis 625 mg	67327	A	J01CR02	2019-07-24
Dapagliflozin Devatis 5 mg	69746	B	A10BK01	2025-01-16
Eltrombopag Devatis 12	70153	A	B02BX05	2025-12-16
Exemestan Devatis 25 mg	65909	B	L02BG06	2016-03-11
Fingolimod Devatis 0.25 mg	68406	B	L04AE01	2022-03-22
Hydroxycarbamid Devatis 500 mg	67491	A	L01XX05	2019-10-28
Imatinib Devatis 100 mg (teilbar)	65580	A	L01XE01	2015-10-09
Imatinib GIST Devatis 100 mg	69961	A	L01EA01	2025-07-28
Lenalidomid Devatis 2.5 mg	68518	A	L04AX04	2022-01-12
Letrozol Devatis 2.5 mg	65923	B	L02BG04	2016-07-19
Levodopa / Benserazid Devatis 62.5 mg (50 mg + 12.5 mg)	68472	B	N04BA02	2021-12-01
Pomalidomid Devatis 1 mg	70239	A	L04AX06	2025-12-11
Posaconazol Devatis 100 mg	69323	B	J02AC04	2024-05-08
Posaconazol Devatis 40mg/ml	67594	B	J02AC04	2020-08-06
Ruxolitinib Devatis 5 mg	70478	A	L01EJ01	2026-08-24
Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg	69903	B	R03AK06	2025-09-16
Sitagliptin Devatis 25 mg	70219	B	A10BH01	2026-05-01
Tadalafil Devatis 5 mg	70000	B	G04BE08	2026-01-19
Tadalafil PAH Devatis 20 mg	70001	B	G04BE08	2026-01-19
Temozolomid Devatis 5 mg	68606	A	L01AX03	2022-11-17
Teriflunomid Devatis 14 mg	69756	B	L04AK02	2025-02-25
Ticagrelor Devatis 60 mg	69816	B	B01AC24	2025-12-16
Tofacitinib Devatis 5 mg	69213	B	L04AF01	2025-06-19

Frequently asked questions

How many medicines does Devatis AG have authorised in Switzerland?

Devatis AG is recorded by Swissmedic as the authorisation holder for 34 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.

Where is Devatis AG based?

The Swiss location recorded for Devatis AG is Cham, Zug.

Is Devatis AG a Swissmedic authorisation holder?

Yes. Devatis AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.

Sources

Last updated: 17 September 2026

Data from the Swissmedic list of authorised medicinal products as of 1 September 2026. Location, sector and website added by our own research.

About the operator

Swiss Pharma Partners

Public sources · Independent directory · Eight language versions

The Swiss Pharma Partners is an independent service and is neither affiliated with nor authorised by Swissmedic or the Federal Office of Public Health (FOPH).